 LONDON, UK ACCESSWIRE May 12, 2020 Midatech Pharma PLC AIM:MTPH.LMTP, a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines announces that China Medical System Holdings Ltd 0867.HK CMS, its concert parties and the Company have mutually agreed to amend the relationship agreement entered into on 29 January 2019 Relationship Agreement. Midatech and the CMS Concert Party have agreed to amend the Relationship Agreement to remove CMS rights to appoint a director and observer to the Board of Midatech. The Company remains in an Offer Period as defined in the Takeover Code in relation to the previously announced Formal Sale Process that is underway as part of the Companys strategic review. 